Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 13, 2019

SELL
$5.7 - $19.7 $3.59 Million - $12.4 Million
-629,599 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$5.57 - $11.65 $1.82 Million - $3.81 Million
-327,185 Reduced 34.2%
629,599 $3.59 Million
Q3 2018

Nov 09, 2018

BUY
$11.32 - $15.7 $1.48 Million - $2.05 Million
130,312 Added 15.77%
956,784 $11.5 Million
Q2 2018

Aug 10, 2018

BUY
$13.5 - $14.52 $11.2 Million - $12 Million
826,472 New
826,472 $11.2 Million

Others Institutions Holding MGTA

About Magenta Therapeutics, Inc.


  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.